Shugaku Takeda

LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer

Masoud Tavazoie, Ilana Pollack, Raissa Tanqueco et al. · Cell · 2018 · 481 citations · Full text

Life Sciences, Immunology, Oncology +10

Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators <i>BAP1</i> and <i>SETD2</i> : A Report by MSKCC and the KIRC TCGA Research Network

A. Ari Hakimi, Irina Ostrovnaya, Boris Reva et al. · Clinical Cancer Research · 2013 · 354 citations

Medicine, Genetics, Oncology +17

An interconnected hierarchical model of cell death regulation by the BCL-2 family

Hui‐Chen Chen, Masayuki Kanai, Akane Inoue‐Yamauchi et al. · Nature Cell Biology · 2015 · 248 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma

A. Ari Hakimi, Ying‐Bei Chen, James Wren et al. · European Urology · 2012 · 229 citations · Full text

Medicine, Cancer Biology, Oncology +12

The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma

Amrita M. Nargund, Can G. Pham, Yiyu Dong et al. · Cell Reports · 2017 · 227 citations · Full text

Medicine, Genetics, Oncology +17